HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stéphanie Mathis Selected Research

tisagenlecleucel

12/2021Determinants of CD19-positive vs CD19-negative relapse after tisagenlecleucel for B-cell acute lymphoblastic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stéphanie Mathis Research Topics

Disease

1Anemia
01/2022
1Paraproteinemias (Monoclonal Gammopathy)
01/2022
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2022
1Cytokine Release Syndrome
12/2021
1Neoplasms (Cancer)
12/2021
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2021
1Leukemia
11/2018

Drug/Important Bio-Agent (IBA)

1ParaproteinsIBA
01/2022
1Immunoglobulins (Immunoglobulin)IBA
01/2022
1tisagenlecleucelIBA
12/2021
1blinatumomabIBA
12/2021
1Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
11/2018

Therapy/Procedure

2Therapeutics
01/2022 - 12/2021